// App-Quantinova.ai

Filters

Biomarkers

No records found for your search

Conference Name

No records found for your search

Country

























Company

Search valid company name..

Conference Year













Drug











Disease

Medical Centers

Search valid medical center name..

Outcomes





Presenter

Search valid presenter name..

Principal Investigators

Search valid principal investigator name..

Phase










Patient Segments

Search valid patient segment..

Result



Sponsor

Search valid sponsor name..

Study ID

Search your valid Study ID..

Therapeutic Area
























28841 Abstracts

Clinical Utility of Thoracic Computed Tomography Body Composition Measures in Idiopathic Pulmonary Fibrosis

A. Vagaon - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Endocrine/metabolic Diseases (ME)

N/A

N/A

Elevation of Plasma Inflammatory Biomarkers in Sarcoidosis

H. Yogasundaram - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Infectious Diseases (ID)

N/A

N/A

Frailty Is an Independent Predictor of Mortality in Patients with Fibrotic Interstitial Lung Disease

S. A. Guler - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

The Effect of Tiotropium/Olodaterol Versus Tiotropium on Breathlessness During the 3-Minute Constant Speed Shuttle Walking Test in Patients with Chronic Obstructive Pulmonary Disease

F. Maltais - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

Tiotropium/olodaterol

Sonographic Assessment of Pulmonary Edema Using B-Line Scores During Incremental Ascent to Altitude

R. Lim - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Cardiovascular (CVS)

N/A

N/A

Fibroblast Growth Factor 10 (FGF10) Haploinsufficiency Is Associated with Smaller Airways Lumen: Implications for Chronic Obstructive Pulmonary Disease (COPD) Susceptibility

H. Traboulsi - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

SK1211

Characterizing Pathological Changes of the Peripheral Airways in Mild and Moderate COPD

S. Booth - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

The Expression of Diacetyl/L-xylulose Reductase (DCXR) in Airway Epithelium in Chronic Obstructive Pulmonary Disease (COPD)

M. Jin - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

Cigarette Smoke Exposure Alters Prenyltransferase Expression and Activity in the Lung

T. H. Mahood - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

The Optimal Dose of Elastase from the Aspect of Lung Compliance in Rat Emphysema Model

T. Wada - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

Elaszym

Impact of Methionine/Choline Deficient Diet and Cigarette Smoke Exposure on Pulmonary Homeostasis

E. Jubinville - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

LT 02

Positive Predictive Value of the SAMSPAP (Sleep Apnea in Multiple Sclerosis Positive Airway Pressure) Trial Eligibility Criteria for Sleep Apnea Diagnosis

S. M. Khadadah - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Dermatology

N/A

N/A

Determination of the Eligibility Criteria for Cancer Care Ontario’s Lung Cancer Screening Pilot for People at High Risk

M. Tammemagi - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Oncology (ONC)

N/A

N/A

Trends of Inhaled Medication Use and Costs in Chronic Obstructive Pulmonary Disease: A 18-Year Population-Based Study

M. Sadatsafavi - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

Emergency Department Management of Acute Exacerbations of Chronic Obstructive Pulmonary Disease (AECOPD): Factors Predicting Readmission

S. F. Van Eeden - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

Healthcare and Research Priorities of Adults with Mild-to-Very Severe COPD

E. Michalovic - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

Workplace Productivity in Patients with Fibrotic Interstitial Lung Disease

M. Algamdi - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

Workplace Productivity in Patients with Connective Tissue Disease Associated Interstitial Lung Disease

M. Algamdi - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Pulmonary/Respiratory Diseases

N/A

N/A

Prone Positioning Decreases Unstable Inflation and Lung Injury Progression After Acid Aspiration

Y. Xin - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

N/A

N/A

N/A

A Clinical Score to Predict Duration of Weaning from Readiness to Extubation

M. Dres - American Thoracic Society (ATS) , 2018

Therapeutic Area

Disease

Drug/Treatment

Central Nervous System (CNS)

N/A

N/A

Copyright © 2026. QuantiNova All rights reserved